Filing Details
- Accession Number:
- 0001127602-25-003227
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-05 16:46:33
- Reporting Period:
- 2025-02-03
- Filing Date:
- 2025-02-05
- Accepted Time:
- 2025-02-05 16:46:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1648929 | Stephen Williamson | 168 Third Avenue Waltham MA 02451 | Sr. Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-03 | 9,825 | $253.99 | 37,121 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-03 | 9,825 | $593.13 | 27,296 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-02-04 | 9,825 | $253.99 | 37,121 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-04 | 9,825 | $585.59 | 27,296 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-03 | 9,825 | $0.00 | 9,825 | $253.99 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-04 | 9,825 | $0.00 | 9,825 | $253.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,825 | 2026-02-26 | No | 4 | M | Direct | |
| 0 | 2026-02-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,674 | Indirect | By SLAT |
Footnotes
- On November 15, 2022, the reporting person contributed 18,700 shares of common stock to a grantor retained annuity trust for the benefit of his children. Upon termination of the trust on 12/11/2024, 0 shares were transferred by the trust to the reporting person's children. The remaining 8,844 shares were previously distributed to the reporting person and continue to be reported in this Form 4 as directly owned.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2024.
- The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
- The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.
Billionaire Hedge Funds
